Around 60,000 patients sustain a cardiac arrest in communities across the UK each year and resuscitation is attempted by the emergency services in approximately half of these patients.

The NHS spends approximately £320 million a year treating cardiac arrest victims. Despite this significant investment, at present only 1 in 20 people survives hospital and is able to go home after a cardiac arrest.

The PARAMEDIC trial will examine if the use of a new mechanical chest compression device (called LUCAS-2) will improve survival and other patient focused outcomes in victims of cardiac arrest.

 

Take a look at our Protocol Paper recently published